Single-Cell Transcriptome Analysis of Peripheral Neutrophils From Patients With Idiopathic Pulmonary Arterial Hypertension

BACKGROUND: Idiopathic pulmonary hypertension (IPAH) is a rare and devastating disease often accompanied by persistent inflammation and immune responses. We aim to provide a reference atlas of neutrophils to facilitate a better understanding of cellular phenotypes and discovery of candidate genes. METHODS: Peripheral neutrophils from naive patients with IPAH and matched controls were profiled. Whole-exon sequencing was performed to exclude known genetic mutations before establishing single-cell RNA sequencing. Marker genes were validated by flow cytometry and histology in a separate validation cohort. RESULTS: Seurat clustering analysis revealed that the landscape of neutrophils encompassed 5 clusters, including 1 progenitor, 1 transition, and 3 functional clusters. The intercorrelated genes in patients with IPAH were mainly enriched in antigen processing presentation and natural killer cell mediated cytotoxicity. We identified and validated differentially upregulated genes, including MMP9 (matrix metallopeptidase 9), ISG15 (ISG15 ubiquitin-like modifier), and CXCL8 (C-X-C motif ligand 8). The positive proportions and fluorescence quantification of these genes were significantly increased in CD16+ neutrophils in patients with IPAH. The higher proportion of positive MMP9 neutrophils increased mortality risk after adjustment for age and sex. Patients with higher proportions of positive MMP9 neutrophils had worse survival, while the fraction of ISG15- or CXCL8-positive expression neutrophils failed to predict outcome. CONCLUSIONS: Our study yields a comprehensive dataset of the landscape of neutrophils in patients with IPAH. The predictive values of a neutrophil cluster characterized by higher MMP9 expression indicate a functional role for neutrophil-specific matrix metalloproteinases in the pathogenesis of pulmonary arterial hypertension.

[1]  Xue Yu,et al.  Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus. , 2022, Journal of autoimmunity.

[2]  M. Snyder,et al.  Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension , 2022, American journal of respiratory and critical care medicine.

[3]  N. Morrell,et al.  New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis , 2022, Circulation research.

[4]  S. Dell’Orso,et al.  Single-Cell Analysis Reveals the Range of Transcriptional States of Circulating Human Neutrophils , 2022, The Journal of Immunology.

[5]  Min Liu,et al.  Cell landscape atlas for patients with chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy constructed using single-cell RNA sequencing , 2021, Aging.

[6]  M. Yeager,et al.  Metalloproteinases and Their Inhibitors Are Associated with Pulmonary Arterial Stiffness and Ventricular Function in Pediatric Pulmonary Hypertension. , 2021, American journal of physiology. Heart and circulatory physiology.

[7]  A. Sweatt,et al.  Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency , 2021, Chest.

[8]  Jason D. Buenrostro,et al.  The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments , 2021, Nature Communications.

[9]  Zhi-jie Liu,et al.  Structural insights into the activation of chemokine receptor CXCR2 , 2021, The FEBS journal.

[10]  S. Pullamsetti,et al.  Matrix Metalloproteinase-8 in Pulmonary Hypertension: The Sheep in the Wolf’s Skin? , 2021, American journal of respiratory and critical care medicine.

[11]  E. J. Dougherty,et al.  Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension , 2021, Proceedings of the National Academy of Sciences.

[12]  W. Kuebler,et al.  Perivascular Inflammation in Pulmonary Arterial Hypertension , 2020, Cells.

[13]  T. Cheng,et al.  Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection , 2020, Nature Immunology.

[14]  M. Dunning,et al.  Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome , 2020, American journal of respiratory and critical care medicine.

[15]  Qingbo Xu,et al.  Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Humbert,et al.  Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives , 2019, European Respiratory Journal.

[17]  Michael J. T. Stubbington,et al.  Single-cell reconstruction of the early maternal–fetal interface in humans , 2018, Nature.

[18]  M. Rabinovitch,et al.  The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension , 2018, Front. Med..

[19]  D. Lenschow,et al.  ISG15 in antiviral immunity and beyond , 2018, Nature Reviews Microbiology.

[20]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[21]  W. Kuebler,et al.  Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series) , 2018, Pulmonary circulation.

[22]  J. Huibregtse,et al.  Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor. , 2017, Molecules and Cells.

[23]  A. West,et al.  Mitochondrial DNA in innate immune responses and inflammatory pathology , 2017, Nature Reviews Immunology.

[24]  W. Seeger,et al.  Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension. , 2016, International journal of cardiology.

[25]  M. Humbert,et al.  Interferon-induced pulmonary hypertension: an update , 2016, Current opinion in pulmonary medicine.

[26]  R. Goodacre,et al.  Electronic cigarette exposure triggers neutrophil inflammatory responses , 2016, Respiratory Research.

[27]  A. Heger,et al.  UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy , 2016, bioRxiv.

[28]  S. Bozkurt,et al.  Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension , 2015, The Journal of international medical research.

[29]  Hai Li,et al.  Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling. , 2015, American journal of respiratory and critical care medicine.

[30]  M. Humbert,et al.  Pulmonary arterial hypertension in patients treated with interferon , 2014, European Respiratory Journal.

[31]  M. Humbert,et al.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. , 2014, Circulation research.

[32]  W. Seeger,et al.  Matrix metalloproteinases and their inhibitors in pulmonary hypertension , 2012, European Respiratory Journal.

[33]  D. Budd,et al.  Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function. , 2011, Blood.

[34]  R. Trembath,et al.  Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.

[35]  B. Heissig,et al.  Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration. , 2010, Histology and histopathology.

[36]  P. Bruijnzeel,et al.  The pathogenesis of photoaging: the role of neutrophils and neutrophil-derived enzymes. , 2009, The journal of investigative dermatology. Symposium proceedings.

[37]  C. Lloyd,et al.  Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for macrophage markers in murine spleen and liver. , 2008, Journal of immunological methods.

[38]  R. Speich,et al.  Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study , 2008, Respiratory research.

[39]  R. Tal-Singer,et al.  A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist. , 2007, Pulmonary pharmacology & therapeutics.

[40]  A. Lindén Interleukin-17 and airway remodelling. , 2006, Pulmonary pharmacology & therapeutics.

[41]  M. Frid,et al.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. , 2006, The American journal of pathology.

[42]  F. Nielsen,et al.  The transcriptional program of terminal granulocytic differentiation. , 2004, Blood.

[43]  M. Humbert,et al.  Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[44]  W. Seeger,et al.  Increased neutrophil mediator release in patients with pulmonary hypertension – suppression by inhaled iloprost , 2003, Thrombosis and Haemostasis.

[45]  P. E. Van den Steen,et al.  Neutrophil Gelatinase B and Chemokines in Leukocytosis and Stem Cell Mobilization , 2002, Leukemia & lymphoma.

[46]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..